Jaquet et al. found that suppression of PRL secretion by BIM23268, a SRL selective for SST5, was correlated with quantitative SST5 receptor expression among 10 patients with prolactinomas, 3 of which were DA-resistant. Here, PRL is linked to prolactin-producing pituitary gland adenoma.